Tags: technology , affordability , redesigning care , research and discovery

As our understanding of complex genetic testing advances, the need for dynamic clinical networks that analyze, interpret, and react to data in real-time has never been more apparent.

And for the past 10 years, Partners HealthCare has been fortunate to serve as an incubator for GeneInsight, a cutting-edge, responsive gene variance software tool we feel represents a big part of the changing face of medicine in this space

And for the past 10 years, Partners HealthCare has been fortunate to serve as an incubator for GeneInsight, a cutting-edge, responsive gene variance software tool we feel represents a big part of the changing face of medicine in this space.

Sandy Aronson, a founder of GeneInsight, and executive director of information technology for Partners HealthCare’s Personalized Medicine, calls GeneInsight a “continuous learning” infrastructure. It’s an approachable way to describe how this complex medical technology makes the mountains of gene variance data generated per patient easier to track, share, and interpret in real-time.

“These advances will have far-reaching effects on cost reduction and, above all, patient care,”

“This is a platform that has the nuts and bolts you need to focus on reporting out the very best results to patients—not just at the initial test, but with everything we learn about variants over time,” Aronson said.

This is an important point to be made, as the patients best served by GeneInsight are often suffering from—or are at risk of—debilitating disease. Using GeneInsight, laboratories can rely on the software to ensure they’re being given the best, most up-to-date interpretation of a gene variant, and that physicians can respond or adjust treatment accordingly.

"In my view one of the most exciting things in healthcare is the advent of infrastructure with the potential to continuously learn"

Sandy Aronson, a founder of GeneInsight, and executive director of information technology for Partners HealthCare’s Personalized Medicine

GeneInsight’s recent acquisition by Sunquest Information Systems has the software poised to drive down costs even further. In addition, the platform’s transition to the global stage reinforces the commitment we have to pushing the boundaries of clinical science for the benefit of patients and our healthcare system.

Like to stay on the cutting edge? Sign up to receive the latest posts from Connect with Partners.